ArticleBMC cancer2015
Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas.
Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genetics in medicine : official journal of the American College of Medical Genetics · 2018Guideline
- Breast cancer in a patient with neurofibromatosis type 1: A case report and review of literature.Rare tumors · 2025Article
- Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1.Familial cancer · 2023Article
- Breast Cancer Complicated by Cardiac Tamponade in a Patient With Neurofibromatosis Type 1.Cureus · 2023Article
- The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.Familial cancer · 2022Article
- Article
- Surgical dilemma of the management of breast cancer in a patient with neurofibromatosis: case report and a review of the literature.Journal of surgical case reports · 2020Article
- Neurofibromatosis Type 1 with the Development of Pheochromocytoma and Breast Cancer.Internal medicine (Tokyo, Japan) · 2020Article
- Article
- NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.Cancers · 2019Article
- Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.Hereditary cancer in clinical practice · 2019Article
- Neurofibromatosis type 1 and male breast cancer: emerging risk factor?Journal of surgical case reports · 2017Article
- Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.British journal of cancer · 2017Article
- Association between Neurofibromatosis Type 1 and Breast Cancer: A Report of Two Cases with a Review of the Literature.Case reports in medicine · 2015Article
- Neurofibromatosis Type 1 - Association with Breast Cancer, Basal Cell Carcinoma of the Skin, and Low-Grade Peripheral Nerve Sheath Sarcoma: Case Report and Literature Review.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeurofibromatosis 1 is one of the most common genetic diseases in humans, presenting with multiple neurofibromas and an increased risk of various benign and malignant tumors, including breast cancer. CASE PRESENTATION: In this paper we report a case of a woman with neurofibromatosis 1 and the challenge associated with detecting an advanced breast cancer because of numerous skin neurofibromas, which were responsible for a substantial delay in cancer diagnosis. Literature concerning the association of neurofibromatosis 1 and breast cancer is reviewed and discussed.
conclusionsBest practice guidelines for breast cancer detection are not sufficient for the screening of neurofibromatosis 1 carriers. A more intensive clinical and imaging approach should be used if the same early detection rate as in non-neurofibromatosis 1 women is to be achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.